What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Major depressive disorder
His primary areas of investigation include Psychiatry, Clinical psychology, Psychometrics, Depression and Rating scale.
His work in the fields of Bipolar disorder, Electroconvulsive therapy, Anxiety and Mental health overlaps with other areas such as In patient.
His research in Clinical psychology intersects with topics in Hamilton depression scale, Reliability, Cronbach's alpha and Well-being.
His studies deal with areas such as Personality Assessment Inventory, Test validity, Item response theory, Rasch model and SF-36 as well as Psychometrics.
Per Bech interconnects Placebo and Internal medicine, Randomized controlled trial, Epidemiology in the investigation of issues within Depression.
His Rating scale research is multidisciplinary, relying on both Inter-rater reliability and Mania.
His most cited work include:
- The UKU Side Effect Rating Scale. A New Comprehensive Rating Scale for Psychotropic Drugs and a Cross-Sectional Study of Side Effects in Neuroleptic-Treated Patients (1283 citations)
- The WHO-5 Well-Being Index: a systematic review of the literature. (882 citations)
- Translating health status questionnaires and evaluating their quality: The IQOLA Project approach (738 citations)
What are the main themes of his work throughout his whole career to date?
Per Bech mainly focuses on Psychiatry, Depression, Clinical psychology, Psychometrics and Internal medicine.
His Psychiatry study combines topics in areas such as Randomized controlled trial and Quality of life.
His Depression study frequently intersects with other fields, such as Physical therapy.
His biological study spans a wide range of topics, including Rating scale, Personality Assessment Inventory, Item response theory, Rasch model and Melancholia.
He has included themes like Construct validity and Test validity in his Psychometrics study.
As a member of one scientific family, he mostly works in the field of Internal medicine, focusing on Placebo and, on occasion, Anesthesia.
He most often published in these fields:
- Psychiatry (48.97%)
- Depression (34.52%)
- Clinical psychology (33.02%)
What were the highlights of his more recent work (between 2012-2021)?
- Psychiatry (48.97%)
- Depression (34.52%)
- Clinical psychology (33.02%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Psychiatry, Depression, Clinical psychology, Internal medicine and Anxiety.
His work carried out in the field of Psychiatry brings together such families of science as Randomized controlled trial, Psychometrics and Quality of life.
His Psychometrics study integrates concerns from other disciplines, such as Neuroticism and Depressive symptoms.
His Depression research includes elements of Physical therapy and Predictive validity.
His Clinical psychology research integrates issues from Scale, Rating scale, Rasch model, Mental health and Antipsychotic.
His studies deal with areas such as Endocrinology and Treatment-resistant depression as well as Internal medicine.
Between 2012 and 2021, his most popular works were:
- The WHO-5 Well-Being Index: a systematic review of the literature. (882 citations)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the Acute and Continuation Treatment of Unipolar Depressive Disorders (298 citations)
- The Concept of Euthymia. (100 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Major depressive disorder
His primary scientific interests are in Psychiatry, Clinical psychology, Depression, Randomized controlled trial and Rating scale.
His Psychiatry research is multidisciplinary, incorporating perspectives in Quality of life and Psychometrics.
The various areas that he examines in his Clinical psychology study include Clinical trial, Psychotherapist, Mental health, Psychotic depression and Antipsychotic.
Per Bech has researched Depression in several fields, including PsycINFO, Internal medicine and Scale.
The Randomized controlled trial study combines topics in areas such as Antidepressant, Sertraline, Electroconvulsive therapy, Light therapy and Treatment response.
Per Bech works mostly in the field of Rating scale, limiting it down to concerns involving Melancholia and, occasionally, Brief Psychiatric Rating Scale and Research Domain Criteria.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
